Distribuzione geografica
Continente #
NA - Nord America 6087
EU - Europa 862
AS - Asia 425
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 7378
Nazione #
US - Stati Uniti d'America 5970
CN - Cina 379
DE - Germania 204
IT - Italia 195
GB - Regno Unito 155
FI - Finlandia 133
CA - Canada 117
SE - Svezia 97
UA - Ucraina 68
VN - Vietnam 32
IN - India 11
ES - Italia 3
JP - Giappone 3
EU - Europa 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
FR - Francia 1
GR - Grecia 1
IE - Irlanda 1
NL - Olanda 1
NO - Norvegia 1
PT - Portogallo 1
Totale 7378
Città #
Fairfield 1187
Woodbridge 748
Ann Arbor 546
Houston 493
Ashburn 415
Seattle 408
Jacksonville 392
Cambridge 385
Wilmington 382
Chandler 241
Princeton 174
Padova 137
San Diego 125
Munich 121
Mcallen 109
Montréal 109
Beijing 101
Roxbury 76
Nanjing 74
Medford 46
Helsinki 40
Dong Ket 32
Shenyang 30
Des Moines 25
Hebei 24
Norwalk 21
Nanchang 19
Changsha 17
Jinan 16
Hefei 14
Jiaxing 14
Kunming 13
Falls Church 10
Tianjin 10
Borås 5
Indiana 5
Phoenix 5
Rockville 5
Guangzhou 4
Hangzhou 4
Ottawa 4
Redwood City 4
Venice 4
Zhengzhou 4
Buffalo 3
Detroit 3
Fuzhou 3
Haikou 3
New York 3
Ningbo 3
Taizhou 3
Augusta 2
Chengdu 2
Chongqing 2
Hanover 2
Legnaro 2
Mestre 2
Modena 2
Newmarket 2
Shanghai 2
Tokyo 2
Wuhan 2
Anaheim 1
Athens 1
Baotou 1
Brescia 1
Canberra 1
Chaoyang 1
Chicago 1
Cormano 1
Dairago 1
Dublin 1
Groningen 1
Las Vegas 1
Leawood 1
Lisbon 1
London 1
Los Angeles 1
Milton Keynes 1
Nanning 1
Orange 1
Paris 1
Petaluma 1
Regensburg 1
Rovigo 1
San Francisco 1
San Vendemiano 1
Sevilla 1
Sofia 1
São Paulo 1
Taiyuan 1
Toronto 1
Trichiana 1
Venezia 1
Verona 1
White Plains 1
Xian 1
Xining 1
Totale 6677
Nome #
Simulating Inflammation in a Wound Microenvironment Using a Dermal Wound-on-a-Chip Model 554
A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: an application for bladder cancer treatment 165
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 151
Autoimmune gastritis: histology phenotype and OLGA staging. 118
Supercritical carbon dioxide combined with high power ultrasound as innovate drying process for chicken breast 118
vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity 117
A Helicobacter pylori vacuolating toxin mutant that fails to oligomerize has a dominant negative phenotype 116
The lipoprotein HP1454 of Helicobacter pylori regulates T-cell response by shaping T-cell receptor signalling 116
The Helicobacter pylori VacA cytotoxin activates RBL-2H3 cells by inducing cytosolic calcium oscillations 111
TpF1 from Treponema pallidum Activates Inflammasome and Promotes the Development of Regulatory T Cells 107
Toll-like receptors hit calcium. 105
The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation 103
Helicobacter pylori vacuolating cytotoxin: cell intoxication and anion-specific channel activity 102
3D imaging of the 58 kDa cell binding subunit of the Helicobacter pylori cytotoxin 99
The Vibrio cholerae cytolysin promotes activation of mast cell (T helper 2) cytokine production 98
Helicobacter pylori-derived neutrophil-activating protein increases the lifespan of monocytes and neutrophils 98
The neutrophil-activating protein of Helicobacter pylori crosses endothelia to promote neutrophil adhesion in vivo 98
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. 96
Structure and immunomodulatory property relationship in NapA of Borrelia burgdorferi 92
Glibenclamide stimulates fluid secretion in rodent cholangiocytes through a cystic fibrosis transmembrane conductance regulator-independent mechanism. 91
Helicobacter pylori, asthma and allergy 91
The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. 91
The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells 91
Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies 90
Borrelia burgdorferi NapA-Driven Th17 Cell Inflammation in Lyme Arthritis 89
MicroRNA expression profiling in human Barrett's carcinogenesis. 89
Cell vacuolization induced by Helicobacter pylori VacA cytotoxin does not depend on late endosomal SNAREs 87
Reply to letter by Nardelli and Schell commenting on the pathogenesis of Lyme arthritis 87
The concerted action of the Helicobacter pylori cytotoxin VacA and of the v-ATPase proton pump induces swelling of isolated endosomes 87
Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesis 86
Endosome-mitochondria juxtaposition during apoptosis induced by H. pylori VacA. 84
HP-NAP new therapy for bladder cancer: numquam periculum sine periculo vincitur 84
Cytokine BAFF Released by Helicobacter pylori-Infected Macrophages Triggers the Th17 Response in Human Chronic Gastritis. 84
Treponema pallidum (syphilis) antigen TpF1 induces angiogenesis through the activation of the IL-8 pathway 83
The multiple cellular activities of the VacA cytotoxin of Helicobacter pylori 82
Helicobacter pylori affects the antigen presentation activity of macrophages modulating the expression of the immune receptor CD300E through miR-4270 82
Bacterial toxins with intracellular protease activity 80
Cell vacuolization induced by Helicobacter pylori: Inhibition by bafilomycins A1, B1, C1 and D 80
Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells 79
[Therapy for non-muscle invasive bladder cancer: HP-NAP.] 79
Evaluation of the efficacy of the H. Pylori protein HP-NAP as a therapeutic tool for treatment of bladder cancer in an orthotopic murine model 79
Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. 78
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells 78
The effect of Helicobacter pylori on asthma and allergy 76
The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe? 75
The Neutrophil activating protein of Helicobacter pylori promotes T helper type 1 immune responses 74
Cerebrospinal fluid T-regulatory cells recognize Borrelia burgdorferi NAPA in chronic Lyme borreliosis. 74
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis 73
Virulence factors of Helicobacter pylori 73
Stimulation of TH1 response by Helicobacter pylori neutrophil activating protein decreases the protective role of IgE and eosinophils in experimental trichinellosis. 72
The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma 71
Cell vacuolization induced by Helicobacter pylori VacA toxin: cell line sensitivity and quantitative estimation 71
Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori 70
The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity 69
Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol 67
Characterisation of a monoclonal antibody and its use to purify the cytotoxin of Helicobacter pylori 67
Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITA 65
the VacA toxin of Helicobacter pylori identifies a new intermediate filament-interacting protein 61
Supercritical CO2 drying of food matrices 61
The vacuolar ATPase proton pump is present on intracellular vacuoles induced by Helicobacter pylori 59
VacA and HP-NAP Ying and Yang of Helicobacter pylori-associated gastric inflammation 59
The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin 58
IFN-gamma and R-848 dependent activation of human monocyte-derived dendritic cells by Neisseria meningitidis adhesin A. 55
Molecular and Cellular Mechanisms of action of the VacA and HP-NAP virulence factors 54
Helicobacter pylori vacuolating toxin forms anion-selective channels in planar lipid bilayers: Possible implications for the mechanism of cellular vacuolation 54
Tumor Cells and the Extracellular Matrix Dictate the Pro-Tumoral Profile of Macrophages in CRC 53
Helicobacter pylori HP0175 promotes the production of IL-23, IL-6, IL-1 beta and TGF-beta 51
Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin 50
Action site and cellular effects of cytotoxin VacA produced by Helicobacter pylori 46
The Vibrio choleare haemolysin anion channel is required for cell vacuolation and death 46
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by NapA 45
Helicobacter pylori antigenic Lpp20 is a structural homologue of Tipα and promotes epithelial-mesenchymal transition 45
Pathogenesis of Helicobacter pylori infection. 45
The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent 44
The acid activation of Helicobacter pylori toxin VacA: Structural and membrane binding studies 44
An intracellular target for Helicobacter pylori vacuolating toxin - Response from de Bernard and Arico 42
Immunosoppressive and Proinflammatory Activities of the VacA Toxin of Helicobacter pylori 41
Immunosuppression of T(H)2 responses in Trichinelia spiralis infection by Helicobacter pylori neutrophil-activating protein 41
The C2 fragment from Neisseria meningitidis antigen NHBA increases endothelial permeability by destabilizing adherens junctions. 40
Molecular and cellular mechanisms of action of the VacA and HP-NAP virulence factors of Helicobacter pylori 40
BAFfling autoimmune disorders and helicobacter pylori disease: The interplay between BAFF and the Th17 response 40
Identification of Bacterial Factors Able to Promote a Th17 Response in Gastric Mucosa of H. pylori-Infected Patients 39
Identification of the Helicobacter pylori VacA toxin domain active in the cell cytosol 39
Helicobacter pylori vacuolating cytotoxin and neutrophil activating protein 37
The Vibrio cholerae cytolysin (VCC) promotes intestinal chloride secretion and TH2 cytokines production by mucosal mast cells 36
pH responsive liposomes for enhanced local protein delivery to cancer tissues. 34
Chloride secretion in intact human colon induced by the Vibrio cholerae cytolysin 34
Evaluation of the ability of Helicobacter pylori in inducing the production of B cells activating factors: possible implications in the development of MALT lymphomas 33
Supercritical CO2 drying of food matrices 33
Bacterial toxin: intracellular trafficking and target identification. 31
Molecular and cellular activities of Helicobacter pylori pathogenic factors 31
The Vibrio cholerae cytolysin promotes intestinal chloride secretion in Human colon 31
ADP-heptose enables Helicobacter pylori to exploit macrophages as a survival niche by suppressing antigen-presenting HLA-II expression 28
To treat or not to treat Helicobacter pylori to benefit asthma patients 27
Low pH Activates the Vacuolating Toxin of Helicobacter Pylori which Becomes Acid and Pepsin Resistant 27
H-pylori vacuolating cytotoxin A, intracellular enzymes, and gastric inflammation 27
Totale 7459
Categoria #
all - tutte 9861
article - articoli 9166
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 254
Totale 19281

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018236 00448 777 394 10560
2018/2019935 20821 11 167 14171314281
2019/20202116 29510082216 233160 242215 18221310276
2020/20211432 49963588 21068 14171 202162189148
2021/20221524 51184178117 62103 76170 7330159321
2022/2023410 23616590 00 00 0000
Totale 7602